Time on boards
- Boards served
- 1
- Current seats
- 1
- Board service
- 4 years
- Director since
- 2023
4 years of board service in total across 1 board, counting each seat separately. Longest: Amylyx Pharmaceuticals Inc., 3 years.
Amylyx Pharmaceuticals Inc.
Director
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
Amylyx Pharmaceuticals Inc. June 5, 202563.9%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Aug 31, 2026 | Amylyx Pharmaceuticals Inc. | Option exercise | +25,000 | $1.76 | $44,000 |
| Aug 31, 2026 | Amylyx Pharmaceuticals Inc. | Option exercise | +25,000 | $5.05 | $126,250 |
| May 21, 2026 | Amylyx Pharmaceuticals Inc. | Open-market purchase | +3,800 | $13.51 | $51,338 |
| Dec 23, 2025 | Amylyx Pharmaceuticals Inc. | Open-market purchase | +8,100 | $12.45 | $100,845 |
| Sep 5, 2024 | Amylyx Pharmaceuticals Inc. | Open-market purchase | +50,000 | $2.13 | $106,500 |
| Dec 15, 2023 | Amylyx Pharmaceuticals Inc. | Open-market purchase | +4,000 | $14.97 | $59,880 |
| Mar 16, 2023 | Amylyx Pharmaceuticals Inc. | Open-market purchase | +1,000 | $31.99 | $31,990 |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.